text.skipToContent text.skipToNavigation
Customer Notice (16 July 2025)
Bear with us! We’re currently experiencing some intermittent issues with our communications system and our support team is actively working to resolve the issue. In the meantime - if you’re unable to reach us by phone or live chat, please contact us by email on sales@wms.co.uk. We apologise for any inconvenience and appreciate your patience during this time.
  • Cross.svg
    Extensive product ranges
Calling 01685 846666

Revaxis 3 in 1 Diphtheria, tetanus and poliomyelitis (inactivated) vaccine 0.5ml Suspension for injection in pre-filled syringe POM X1

ID:V260 , 637387
Pharmaceutical Product
In Stock
  • Product Requires Refrigeration

Important Notice: Pharma products are sold and shipped exclusively to registered medical professionals at verified medical premises. 

Non-approved buyers: Complete our Online POM Form, and we will notify you once your account is Pharma approved.


What Revaxis is:

 

Suspension for injection in pre-filled syringe - the vaccine has a cloudy white appearance.

Therapeutic indications
• REVAXIS is indicated for active immunisation against diphtheria, tetanus and poliomyelitis in children from six years of age, adolescents and adults as a booster following primary vaccination.
• REVAXIS is not intended for primary immunisation.

Features

Nature and contents of container
0• .5 ml of suspension in pre-filled syringe (0.5 ml, type I glass) with a plunger-stopper (elastomer: bromochlorobutyl or bromobutyl or chlorobutyl) and attached needle and needle-guard (elastomer: synthetic polyisoprene).
• Packs of 1 and 10 syringes.

Special precautions for storage
• Store in a refrigerator (2°C to 8°C).
• Do not freeze. Discard the vaccine if it has been frozen.

Note: As this item requires to be stored between 2 and 8°C, it is considered cold chain supply and so will not be shipped to customers on a Friday.

Patient Information Leaflet:


https://www.medicines.org.uk/emc/files/pil.5581.pdf

Specs
Downloads